Showing 1 - 10 results of 10 for search '"кардиопульмональное нагрузочное тестирование"', query time: 0.55s Refine Results
  1. 1
    Academic Journal

    Source: Russian Journal of Transplantology and Artificial Organs; Том 22, № 3 (2020); 53-61 ; Вестник трансплантологии и искусственных органов; Том 22, № 3 (2020); 53-61 ; 1995-1191 ; 10.15825/1995-1191-2020-3

    File Description: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1227/1000; https://journal.transpl.ru/vtio/article/view/1227/1023; Готье СВ. Инновации в трансплантологии: развитие программы трансплантологии в Российской Федерации. Патология кровообращения и кардиохирур- гия. 2017; 21 (3S): 61–68. doi:10.21688/1681-3472-2017-3s-61-68.; Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-fourth adult lung and heart-lung transplantation report – 2017; Focus Theme: Allograft ischemic time. The Journal of Heart and Lung Transplantation. 2017; 36 (10): 1047–1059. doi:10.1016/j.healun.2017.07.016.; Чернявский АМ, Фомичев АВ, Доронин ДВ, Альсов СА. Опыт трансплантации сердца с длительной холодовой ишемией трансплантата. Вестник трансплантологии и искусственных органов. 2019; 21 (5): 35–35.; Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies RR et al. The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database. The Journal of Thoracic and Cardiovascular Surgery. 2007; 133 (2): 554–559. doi:10.1016/j.jtcvs.2006.09.019.; Currie ME, Shudo Y, Woo YJ. Successful outcome following orthotopic heart transplantation with a donor half way across the country. Transplantation Proceedings. 2018; 50 (10): 4062–4063. doi:10.1016/j.transproceed.2018.09.014.; Reich HJ, Kobashigawa JA, Aintablian T, Ramzy D, Kittleson MM, Esmailian F. Effects of older donor age and cold ischemic time on long-term outcomes of heart transplantation. Texas Heart Institute Journal. 2018; 45 (1): 17–22. doi:10.14503/thij-16-6178.; Fernandez J, Aranda J, Mabbot S, Weston M, Cintron G. Overseas procurement of donor hearts: ischemic time effect on postoperative outcomes. Transplantation Proceedings. 2001; 33 (7–8): 3803–3804. doi:10.1016/s0041-1345(01)02610-0.; Erasmus M, Neyrink A, Sabatino M, Potena L. Heart allograft preservation. Current Opinion in Cardiology. 2017; 32 (3): 292–300. doi:10.1097/hco.0000000000000395.; Mitropoulos FA, Odim J, Marelli D, Karandikar K, Gjertson D, Ardehali A et al. Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study. European Journal of Cardio-Thoracic Surgery. 2005; 28 (1): 143–148. doi:10.1016/j.ejcts.2005.01.067.; Альсов СА, Фомичев АВ, Доронин ДВ, Шмырев ВА, Осипов ДЕ, Чернявский АМ. Клинический случай трансплантации сердца с предельно длительной холодовой ишемией донорского органа. Вестник трансплантологии и искусственных органов. 2018; 20 (1): 110–113. doi:10.15825/1995-1191-2018-1-110-113.; Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R et al. The registry of the International Society for Heart and Lung Transplantation: Twentyseventh official adult heart transplant report – 2010. The Journal of Heart and Lung Transplantation. 2010; 29 (10): 1089–1103. doi:10.1016/j.healun.2010.08.007.; Nicoara A, Ruffin D, Cooter M, Patel CB, Thompson A, Schroder JN et al. Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors. American Journal of Transplantation. 2017; 18 (6): 1461–1470. doi:10.1111/ajt.14588.; Yellon DM, Hausenloy DJ. Myocardial Reperfusion Injury. New England Journal of Medicine. 2007; 357 (11): 1121–1135. doi:10.1056/nejmra071667.; Сологуб ТВ, Романцова МГ, Кремень НВ, Александрова ЛМ, Аникина ОВ, Суханов ДС и др. Свободно-радикальные процессы и воспаление (патогенетические, клинические и терапевтические аспекты). Учебное пособие для врачей. М.: Академия естествознания (2008).; Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M et al. Prolonged cardiac allograft ischemic time – no impact on long-term survival but at what cost? Clinical Transplantation. 2007; 21 (3): 321–329. doi:10.1111/j.1399-0012.2007.00644.x.; Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations. Circulation. 2016; 133 (24): e694–e711. doi:10.1161/cir.0000000000000406.; Tsai WJ, Tsai HY, Kuo LY, Lin YS, Chen BY, Lin WH et al. VE/VCO 2 Slope and Functional Capacity in Patients Post-Heart Transplantation. Transplantation Proceedings. 2018; 50 (9): 2733–17377. doi:10.1016/j.transproceed.2018.05.010.; Uithoven K, Smith J, Medina-Inojosa J, Squires R, Van Iterson E, Olson T. Clinical and Rehabilitative Predictors of Peak Oxygen Uptake Following Cardiac Transplantation. Journal of Clinical Medicine. 2019; 8 (1): 119. doi:10.3390/jcm8010119.; Логинова ИЮ, Каменская ОВ, Чернявский АМ, Доронин ДВ, Альсов СА, Ломиворотов ВН. Динамика парциального давления углекислого газа в конечной порции выдоха при кардиопульмональном нагрузочном тестировании до и после трансплантации сердца. Вестник трансплантологии и искусственных органов. 2019; 21 (2): 16–22. doi:10.15825/1995-1191-2019-2-16-22.; Yeen W, Polgar A, Guglin M, Downes K, Faber C, Roy A et al. Outcomes of Adult Orthotopic Heart Transplantation With Extended Allograft Ischemic Time. Transplantation Proceedings. 2013; 45 (6): 2399–2405. doi:10.1016/j.transproceed.2013.04.003.; Slegtenhorst BR, Dor FJ, Elkhal A, Rodriguez H, Yang X, Edtinger K et al. Mechanisms and consequences of injury and repair in older organ transplants. Transplantation. 2014; 97 (11): 1091–1099. doi:10.1097/tp.0000000000000072.; Chew HC, Macdonald PS, Dhital KK. The donor heart and organ perfusion technology. Journal of Thoracic Disease. 2019; 11 (S6): S938–S945. doi:10.21037/jtd.2019.02.59.; https://journal.transpl.ru/vtio/article/view/1227

  2. 2
    Academic Journal

    Source: The Russian Archives of Internal Medicine; Том 10, № 1 (2020); 47-56 ; Архивъ внутренней медицины; Том 10, № 1 (2020); 47-56 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2020-10-1

    File Description: application/pdf

    Relation: https://www.medarhive.ru/jour/article/view/999/873; https://www.medarhive.ru/jour/article/view/999/883; Саркоидоз. Клинические рекомендации. Москва: РРО; 2019. [Электронный ресурс]. URL: http://spulmo.ru/obrazovatelnyeresursy/federalnye-klinicheskie-rekomendatsii/. (дата обращения: 22.09.2019).; Черников А.Ю., Землянских Л.Г. Качество жизни пациентов с гранулематозным поражением органов дыхания при саркоидозе и туберкулезе. Туберкулёз и болезни лёгких. 2016;94(12):48-52. doi:10.21292/2075-1230-2016-94-12-48-52.; Judson M.A. Quality of life in sarcoidosis. Seminars in respiratory and critical care medicine. 2017;38(4):546-58. doi:10.1055/s0037-1602589.; Marcellis R., Lenssen A., Drent M. et al. Association between physical functions and quality of life in sarcoidosis. Sarcoidosis vasculitis and diffuse lung disease. 2014;31(2):117-28.; Marcellis R.G., Lenssen A.F., Elfferich M.D. et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J. 2011; 38: 628–34.; Pilzak K., Żebrowska A., Sikora M. et al. Physical functioning and symptoms of chronic fatigue in sarcoidosis patients. Adv Exp Med Biol. 2018; 1040: 13-21. doi:10.1007/5584_2017_85.; Bahmer T., Watz H., Develaska M. et al. Physical activity and fatigue in patients with sarcoidosis. Respiration. 2018;95(1):18-26. doi:10.1159/000481827.; Marcellis, R.G.J., Lenssen, A.F., De Vries G.J. et al. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Lung. 2013;191(1):43-52. doi:10.1007/s00408-012-9432-6.; Lopes A.J., Menezes S.L.S., Dias C.M. et al. Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis. Brazilian Journal of Medical and Biological Research. 2012;45(3):256-63. doi:10.1590/S0100-879X2012007500018.; Jastrzębski D., Ziora D., Lubecki M. et al. Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life. Adv Exp Med Biol. 2015; 833: 31-6. doi:10.1007/5584_2014_18; Kostorz S., Jastrzębski D., Sikora M., et al. Predominance of Comorbidities in the Detriment of Daily Activity in Sarcoidosis Patients. Advs Exp. Medicine, Biology — Neuroscience and Respiration. 2018; 1040: 7-12. doi:10.1007/5584_2017_87.; ATS/ACCP statement on cardiopulmonary exercise testing. American journal of respiratory and critical care medicine. 2003;167(2):211-77. doi:10.1164/rccm.167.2.211.; Ward S.A., Palange P. (ed.). Clinical Exercise Testing. European Respiratory Society. 2007;40(12):245 р. ISSN 1025-448x.; Gvozdenovic B.S., Mihailovic-Vucinic V., Ilic-Dudvarski A. et al. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respiratory Medicine. 2008;102(11):1636-42. doi:10.1016/j.rmed.2008.05.001.; Birnie D.H., Sauer W.H., Bogun F. et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014; 11(7):1305-23. doi:10.1016/j.hrthm.2014.03.043.; Визель И.Ю., Шмелев Е.И., Визель А.А. и др. Сравнение вновь выявленных больных саркоидозом молодого и старшего возраста. РМЖ. 2018;10(I):16-20.; Bourbonnais J.M., Samavati L. Effect of gender on health-related quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(2):96-102.; Michielsen H.J., Peros-Golubicic T., Drent M. et al. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration. 2007;74 (4):401-5.; Karadallı M.N., Boşnak-Güçlü M., Camcıoğlu B. et al. Effects of Inspiratory Muscle Training in Subjects with Sarcoidosis: A Randomized Controlled Clinical Trial. Respir Care. 2016;61(4):483-94. doi:10.4187/respcare.04312.; https://www.medarhive.ru/jour/article/view/999

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10